Ali Satvat
KKR | Director
Ali joined KKR in their Menlo Park, CA office in 2012 and is a Member of KKR on the Health Care industry team within KKR’s Americas Private Equity platform. He leads KKR’s Health Care Strategic Growth investing efforts and sits on the Health Care Strategic Growth Investment Committee and the Health Care Strategic Growth Portfolio Management Committee. He currently serves on the boards of directors of AcuFocus, Arbor Pharmaceuticals, Blue Sprig Pediatrics, BridgeBio Pharma, Cohera Medical, Coherus BioSciences, PRA Health Sciences, Slayback Pharma and Trilogy MedWaste and is also involved in KKR’s investments in Ajax Health and Spirox.
Prior to joining KKR, Ali was a principal with Apax Partners, where he invested in health care and was actively involved with many of the firm’s successful private equity and growth equity investments. Previously, Ali held various positions with Johnson & Johnson Development Corporation, Audax Group and The Blackstone Group. Ali holds an A.B., magna cum laude, in History and Science from Harvard College and an M.B.A. in Health Care Management and Entrepreneurial Management from the Wharton School of the University of Pennsylvania. Ali is a member of the board of directors of the Healthcare Private Equity Association.
